Add BrightSurf on Google Email

The tiger mosquito can transmit the chikungunya virus in temperate conditions

Scientists have found that tiger mosquitoes can transmit the chikungunya virus as effectively at 20°C as at 28°C, raising concerns about its spread in temperate regions. The study reveals different gene expression profiles and microbiome changes in infected mosquitoes, which could lead to increased transmission of the pathogen.

SourceInstitut Pasteur·JournalJournal of Travel Medicine·TypeExperimental study·DateJun 14, 2023

Sixteen years of analysis of Brazilian research funding indicates stagnation—and that chikungunya, Chagas disease, schistosomiasis and malaria are systematically underfunded, even among neglected tropical diseases

A 16-year analysis of Brazilian research funding reveals stagnant funding for neglected tropical diseases, including chikungunya, Chagas disease, schistosomiasis, and malaria. Systematic underfunding is observed even among these diseases, which are considered neglected tropical diseases.

SourcePLOS·JournalPLOS Neglected Tropical Diseases·DateMar 16, 2023

New synthetic skin may unlock blood-sucking secrets of mosquitoes

Researchers have developed a new synthetic skin, made of hydrogels, to study how mosquitoes transmit deadly diseases. The hydrogel system can mimic different blood vessel patterns, allowing for more consistent testing and analysis. This breakthrough may help identify ways to prevent the spread of disease.

SourceTulane University·JournalFrontiers in Bioengineering and Biotechnology·TypeExperimental study·DateFeb 9, 2023

Bite this! Mosquito feeding chamber uses fake skin, real blood

Rice University researchers have developed an innovative system to study mosquito feeding behavior using fake skin made with a 3D printer, eliminating the need for live volunteers. The system was tested on various mosquito repellents and showed promising results, suggesting it could be scaled up for future studies.

SourceRice University·JournalFrontiers in Bioengineering and Biotechnology·TypeExperimental study·DateFeb 9, 2023

Acoziborole: Investigational single-dose oral treatment raises hope for elimination of sleeping sickness in Africa

The Phase II/III study found that acoziborole has an 18-month treatment success rate of 95% for late-stage patients and 100% for early-stage patients, with no significant safety concerns reported. This breakthrough could lead to the elimination of sleeping sickness through a simplified 'screen-and-treat' approach.

SourceDrugs for Neglected Diseases Initiative·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateNov 30, 2022

THE LANCET INFECTIOUS DISEASES: New single-dose treatment for sleeping sickness could help eliminate transmission of the disease by 2030

A new study found that a single dose of acoziborole is as effective as current treatments for sleeping sickness, with a cure rate of 95% for late-stage patients and 100% for early/intermediate-stage patients. The treatment could revolutionize treatment for the disease by eliminating barriers such as hospitalization and travel distances.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·TypeExperimental study·DateNov 29, 2022

Climate factors predict future mosquito activity

A new study finds that climate variables like temperature, rainfall, and ocean warming predict mosquito population growth in Sri Lanka for the next one to six months. The research can inform programs to limit dengue transmission, a major public health problem in the country.

SourceNew York University·JournalThe Lancet Planetary Health·DateJul 6, 2022

Modeling a devastating childhood disease on a chip

A team of researchers created an in vitro human model of environmental enteric dysfunction (EED) using the Human Organ Chip technology. The EED Chips recapitulate features of EED found in biopsies from human patients, including inflammation and intestinal barrier dysfunction. The study sheds light on the complex interplay between malnu...

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalNature Biomedical Engineering·TypeExperimental study·DateJun 23, 2022

THE LANCET INFECTIOUS DISEASES: Study reports first use of antivirals in monkeypox patients, highlighting challenges in understanding and treating this rare disease

A new retrospective study analyzed seven patients with monkeypox in the UK between 2018 and 2021, suggesting potential benefits of antiviral medications like tecovirimat. However, brincidofovir showed little clinical benefit and raised concerns about liver toxicity.

SourceThe Lancet·JournalThe Lancet Infectious Diseases·TypeCase study·DateMay 24, 2022

Mapping of exposed water tanks and swimming pools based on aerial images can help control dengue

Researchers in Brazil developed a computer program that locates swimming pools and rooftop water tanks in aerial photographs, using artificial intelligence to identify socio-economically deprived urban areas at risk for diseases transmitted by Aedes aegypti. The innovation can be used as a public policy tool for dynamic socio-economic ...

COVID-19 restrictions linked to nearly 750,000 fewer dengue cases in 2020

A new study found a strong association between school closures and declines in non-residential trips during COVID-19, leading to reduced risk of dengue transmission. Reduced time spent in public areas was closely associated with reduced dengue risk in countries where COVID-19 restriction measures began at the peak of dengue season.

SourceLondon School of Hygiene & Tropical Medicine·JournalThe Lancet Infectious Diseases·DateMar 2, 2022

New evidence that mass treatment with Ivermectin has halted spread of river blindness in two Nigerian states; Separate study shows drug’s potential to interrupt West Nile Virus transmission in US

Mass treatment with Ivermectin has halted the spread of river blindness in two Nigerian states, Plateau and Nasarawa, marking a major milestone in disease elimination efforts. Separate studies also show the potential for Ivermectin to reduce West Nile Virus transmission by mixing it into bird feed.

SourceAmerican Society of Tropical Medicine & Hygiene·JournalAmerican Journal of Tropical Medicine and Hygiene·DateNov 18, 2021

Children repeatedly exposed to malaria from birth are more likely to be anemic by the age of two

A Brazilian study found that children exposed to malaria from birth are more likely to develop anemia by age two. The researchers, led by Dr. Marly Augusto Cardoso, followed 1,539 children and discovered that 12.6% were anemic, with a higher prevalence in rural areas not covered by the study.

SourceFundação de Amparo à Pesquisa do Estado de São Paulo·JournalPLOS Neglected Tropical Diseases·DateOct 13, 2021

'Smart collar' could prevent tapeworms in dogs

Researchers developed a smart collar that delivers praziquantel, a deworming drug, to dogs infected with echinococcosis. The collar reduces the risk of tapeworms in dogs by 0.182 times and 0.336 times compared to control groups.

SourcePLOS·JournalPLOS Neglected Tropical Diseases·DateJul 8, 2021

Tap water access linked to dengue risk

Researchers have identified tap water access as a strong predictor of dengue risk in urban environments. Poorly accessed colonies showed higher risks of exposure and recent infection compared to wealthier areas, highlighting the need for targeted mosquito control measures.

SourcePLOS·JournalPLOS Neglected Tropical Diseases·DateFeb 11, 2021